{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:20:26Z","timestamp":1769120426877,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ratchadapisek Sompoch Endowment Fund of Chulalongkorn University","award":["#RA24\/53."],"award-info":[{"award-number":["#RA24\/53."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Our study aimed to determine the prevalence and prognosis of acute coronary syndrome with non-obstructive coronary artery (ACS-NOCA) in patients with hypertrophic cardiomyopathy (HCM).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and results<\/jats:title>\n                <jats:p>We enrolled\u00a0a total of 200 consecutive patients with HCM over a 139-month period from 2002 to 2013. The study found that 28 patients (14% of overall patients, 51% of patients with ACS) had ACS-NOCA, and 18 patients (9% of overall patients, 86% of patients with acute MI) had MINOCA as initial clinical presentations. The highest prevalence of non-obstructive coronary artery disease (NOCA) in patients with HCM was found in acute ST-elevation myocardial infarction (STEMI) (100%), followed by non-STEMI (82%), and unstable angina (29%). Patients with ACS-NOCA had more frequent ventricular tachycardia and lower resting left ventricular (LV) outflow tract gradients than those with no ACS-NOCA (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05 for all). The ACS-NOCA group had a lower probability of HCM-related death compared with the no ACS-NOCA group and the significant coronary artery disease (CAD) group (p-log-rank\u2009=\u20090.0018).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MINOCA or ACS-NOCA is not an uncommon initial presentation (prevalence rate 9\u201314%) in patients with HCM. NOCA was highly prevalent (51\u201386%) in patients with HCM presenting with ACS and had a favorable prognosis. Our findings highlight as a reminder that in an era of rapid reperfusion therapy, ACS in patients with HCM is not only a result of obstructive epicardial CAD, but also stems from the complex cellular mechanisms of myocardial necrosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-021-02373-z","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T12:11:32Z","timestamp":1637323892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy"],"prefix":"10.1186","volume":"21","author":[{"given":"Sarinya","family":"Puwanant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angkawipa","family":"Trongtorsak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaisiri","family":"Wanlapakorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nattakorn","family":"Songsirisuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aekarach","family":"Ariyachaipanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smonporn","family":"Boonyaratavej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"key":"2373_CR1","doi-asserted-by":"crossref","unstructured":"Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995; 92(4): 785\u20139.","DOI":"10.1161\/01.CIR.92.4.785"},{"issue":"5","key":"2373_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0735-1097(03)00854-4","volume":"42","author":"P Sorajja","year":"2003","unstructured":"Sorajja P, Ommen SR, Nishimura RA, Gersh BJ, Tajik AJ, Holmes DR. Myocardial bridging in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003;42(5):889\u201394.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2373_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0002-9149(76)90056-4","volume":"38","author":"A Walston II","year":"1976","unstructured":"Walston A II, Behar VS. Spectrum of coronary artery disease in idiopathic hypertrophic subaortic stenosis. Am J Cardiol. 1976;38(1):12\u20136.","journal-title":"Am J Cardiol"},{"issue":"4","key":"2373_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0002-9149(92)91197-C","volume":"70","author":"E Lazzeroni","year":"1992","unstructured":"Lazzeroni E, Rolli A, Aurier E, Botti G. Clinical significance of coronary artery disease in hypertrophic cardiomyopathy. Am J Cardiol. 1992;70(4):499\u2013501.","journal-title":"Am J Cardiol"},{"issue":"4","key":"2373_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1378\/chest.64.4.529-a","volume":"64","author":"WA Kossowsky","year":"1973","unstructured":"Kossowsky WA, Mohr B, Dardashti I, Gabor GE. Acute myocardial infarction in idiopathic hypertrophic subaortic stenosis. Chest. 1973;64(4):529\u201332.","journal-title":"Chest"},{"issue":"3","key":"2373_CR6","first-page":"305","volume":"75","author":"M Bachik","year":"1983","unstructured":"Bachik M, Agarwal SK, Haft JI. Idiopathic hypertrophic subaortic stenosis and acute myocardial infarction: an uncommon association. J Natl Med Assoc. 1983;75(3):305\u20139.","journal-title":"J Natl Med Assoc"},{"issue":"13","key":"2373_CR7","first-page":"828","volume":"69","author":"JZ Przybojewski","year":"1986","unstructured":"Przybojewski JZ, van der Walt JJ, Tiedt FA. Hypertrophic obstructive cardiomyopathy with pseudo-myocardial infarction pattern: a case report. S Afr Med J. 1986;69(13):828\u201332.","journal-title":"S Afr Med J"},{"issue":"3","key":"2373_CR8","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/j.ijcard.2008.04.038","volume":"135","author":"S Patane","year":"2009","unstructured":"Patane S, Marte F, Di Bella G, Chiribiri A. Acute myocardial infarction with diminutive right coronary artery and obstructive hypertrophic cardiomyopathy without significant coronary stenoses. Int J Cardiol. 2009;135(3):e73\u20135.","journal-title":"Int J Cardiol"},{"issue":"1","key":"2373_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0167-5273(01)00442-9","volume":"80","author":"T Sayin","year":"2001","unstructured":"Sayin T, Kocum T, Kervancioglu C. Apical hypertrophic cardiomyopathy mimics acute coronary syndrome. Int J Cardiol. 2001;80(1):77\u20139.","journal-title":"Int J Cardiol"},{"key":"2373_CR10","doi-asserted-by":"crossref","unstructured":"Lewis EF, Edelman ER. Images in cardiovascular medicine. Acute ST depressions in a patient with idiopathic hypertrophic subaortic stenosis and normal coronary arteries. Circulation 2002; 106(6): 757\u20138.","DOI":"10.1161\/01.CIR.0000024108.79612.E3"},{"key":"2373_CR11","unstructured":"Ommen SR, Mital S, Burke MA, et al. 2020 AHA\/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy. J Am Coll Cardiol; 0(0)."},{"issue":"20","key":"2373_CR12","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618\u201351.","journal-title":"Circulation"},{"issue":"25","key":"2373_CR13","first-page":"e344","volume":"130","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. Circulation. 2014;130(25):e344\u2013426.","journal-title":"Circulation"},{"key":"2373_CR14","doi-asserted-by":"crossref","unstructured":"Dehmer GJ, Badhwar V, Bermudez EA, et al. 2020 AHA\/ACC Key Data Elements and Definitions for Coronary Revascularization: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization). Circ: Cardiovasc Qual Outcomes 2020; 13(4): e000059.","DOI":"10.1161\/HCQ.0000000000000059"},{"issue":"20","key":"2373_CR15","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1161\/CIRCULATIONAHA.117.030798","volume":"136","author":"E Puymirat","year":"2017","unstructured":"Puymirat E, Simon T, Cayla G, et al. Acute myocardial infarction. Circulation. 2017;136(20):1908\u201319.","journal-title":"Circulation"},{"issue":"6","key":"2373_CR16","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/0002-9149(79)90139-5","volume":"43","author":"BJ Maron","year":"1979","unstructured":"Maron BJ, Epstein SE, Roberts WC. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol. 1979;43(6):1086\u2013102.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2373_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/clc.22601","volume":"40","author":"YJ Yang","year":"2017","unstructured":"Yang YJ, Fan CM, Yuan JQ, et al. Long-term survival after acute myocardial infarction in patients with hypertrophic cardiomyopathy. Clin Cardiol. 2017;40(1):26\u201331.","journal-title":"Clin Cardiol"},{"issue":"19","key":"2373_CR18","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1161\/01.CIR.0000097110.55312.BF","volume":"108","author":"P Sorajja","year":"2003","unstructured":"Sorajja P, Ommen SR, Nishimura RA, Gersh BJ, Berger PB, Tajik AJ. Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation. 2003;108(19):2342\u20138.","journal-title":"Circulation"},{"issue":"8","key":"2373_CR19","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.amjmed.2015.02.025","volume":"128","author":"T Gupta","year":"2015","unstructured":"Gupta T, Harikrishnan P, Kolte D, et al. Outcomes of acute myocardial infarction in patients with hypertrophic cardiomyopathy. Am J Med. 2015;128(8):879-87.e1.","journal-title":"Am J Med"},{"issue":"4","key":"2373_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1161\/01.CIR.65.4.778","volume":"65","author":"A Pasternac","year":"1982","unstructured":"Pasternac A, Noble J, Streulens Y, Elie R, Henschke C, Bourassa MG. Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation. 1982;65(4):778\u201389.","journal-title":"Circulation"},{"issue":"3","key":"2373_CR21","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0735-1097(01)01461-9","volume":"38","author":"BW McCrindle","year":"2001","unstructured":"McCrindle BW, Yetman AT. Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2001;38(3):921\u20132.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"2373_CR22","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.jacc.2016.07.751","volume":"68","author":"CE Raphael","year":"2016","unstructured":"Raphael CE, Cooper R, Parker KH, et al. Mechanisms of myocardial ischemia in hypertrophic cardiomyopathy: insights from wave intensity analysis and magnetic resonance. J Am Coll Cardiol. 2016;68(15):1651\u201360.","journal-title":"J Am Coll Cardiol"},{"key":"2373_CR23","doi-asserted-by":"crossref","unstructured":"Aguiar Rosa S, Rocha Lopes L, Fiarresga A, Ferreira RC, Mota Carmo M. Coronary microvascular dysfunction in hypertrophic cardiomyopathy: pathophysiology, assessment, and clinical impact. Microcirculation 2020: e12656.","DOI":"10.1111\/micc.12656"},{"issue":"18","key":"2373_CR24","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","volume":"115","author":"SE Petersen","year":"2007","unstructured":"Petersen SE, Jerosch-Herold M, Hudsmith LE, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation. 2007;115(18):2418\u201325.","journal-title":"Circulation"},{"key":"2373_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijcard.2019.03.060","volume":"291","author":"A Fo\u00e0","year":"2019","unstructured":"Fo\u00e0 A, Agostini V, Rapezzi C, et al. Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy. Int J Cardiol. 2019;291:77\u201382.","journal-title":"Int J Cardiol"},{"issue":"9","key":"2373_CR26","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.amjcard.2020.02.002","volume":"125","author":"N van der Velde","year":"2020","unstructured":"van der Velde N, Huurman R, Yamasaki Y, et al. Frequency and significance of coronary artery disease and myocardial bridging in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2020;125(9):1404\u201312.","journal-title":"Am J Cardiol"},{"issue":"17","key":"2373_CR27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJM199810223391704","volume":"339","author":"AT Yetman","year":"1998","unstructured":"Yetman AT, McCrindle BW, MacDonald C, Freedom RM, Gow R. Myocardial bridging in children with hypertrophic cardiomyopathy: a risk factor for sudden death. N Engl J Med. 1998;339(17):1201\u20139.","journal-title":"N Engl J Med"},{"issue":"8","key":"2373_CR28","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.amjcard.2019.07.024","volume":"124","author":"M Nassar","year":"2019","unstructured":"Nassar M, Arow Z, Monakier D, et al. Effect of intramural course of coronary arteries assessed by computed tomography angiography in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2019;124(8):1279\u201385.","journal-title":"Am J Cardiol"},{"issue":"5","key":"2373_CR29","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.ahj.2004.07.029","volume":"149","author":"B Dawn","year":"2005","unstructured":"Dawn B, Paliwal VS, Raza ST, Mastali K, Longaker RA, Stoddard MF. Left ventricular outflow tract obstruction provoked during dobutamine stress echocardiography predicts future chest pain, syncope, and near syncope. Am Heart J. 2005;149(5):908\u201316.","journal-title":"Am Heart J"},{"issue":"3","key":"2373_CR30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jacc.2009.04.026","volume":"54","author":"DH Kwon","year":"2009","unstructured":"Kwon DH, Smedira NG, Rodriguez ER, et al. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol. 2009;54(3):242\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2373_CR31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.hlc.2008.03.080","volume":"17","author":"T Suk","year":"2008","unstructured":"Suk T, Edwards C, Hart H, Christiansen JP. Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients. Heart Lung Circ. 2008;17(5):370\u20134.","journal-title":"Heart Lung Circ"},{"issue":"16","key":"2373_CR32","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.109.850297","volume":"122","author":"NA Khan","year":"2010","unstructured":"Khan NA, Grubisic M, Hemmelgarn B, Humphries K, King KM, Quan H. Outcomes after acute myocardial infarction in South Asian, Chinese, and white patients. Circulation. 2010;122(16):1570\u20137.","journal-title":"Circulation"},{"issue":"9","key":"2373_CR33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5694\/mja15.00504","volume":"203","author":"DB Brieger","year":"2015","unstructured":"Brieger DB, Chew DP, Redfern J, et al. Survival after an acute coronary syndrome: 18-month outcomes from the Australian and New Zealand SNAPSHOT ACS study. Med J Aust. 2015;203(9):368.","journal-title":"Med J Aust"},{"issue":"1","key":"2373_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.amjcard.2004.03.024","volume":"94","author":"AT Yan","year":"2004","unstructured":"Yan AT, Tan M, Fitchett D, et al. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). Am J Cardiol. 2004;94(1):25\u20139.","journal-title":"Am J Cardiol"},{"key":"2373_CR35","doi-asserted-by":"crossref","unstructured":"Valgimigli M, Gragnano F, Branca M, et al. P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials. The BMJ 2021; 373, n1332.","DOI":"10.1136\/bmj.n1332"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02373-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02373-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02373-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T12:14:55Z","timestamp":1637324095000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02373-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2373"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02373-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,19]]},"assertion":[{"value":"21 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of Faculty of Medicine, Chulalongkorn University (IRB 394\/60).  The need for consent was waived by the Institutional Review Board of Faculty of Medicine, Chulalongkorn University with a formal IRB exemption as an observational study with anonymized information does not require an informed consent. All methods were carried out in accordance with the tenets of the Declaration of Helsinki and the Chulalongkorn Research guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"556"}}